Sartorius Stedim Biotech S.A.
Sector and Industry
Healthcare, Healthcare Equipment
Performance (1Y)
10.62%
Market Cap
24.50 Bil.
P/E Ratio
76.93
Dividend Yield
0.33 %
Earnings per Share
2.73 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| Abbott Laboratories | 185.26 Bil. | 39.29 Bil. | 33.69 | -53.32 % | 0.00 | - |
| Intuitive Surgical Inc | 171.24 Bil. | 8.92 Bil. | 71.93 | +17.90 % | 0.00 | - |
| Boston Scientific Corp | 120.40 Bil. | 17.79 Bil. | 49.17 | +49.88 % | 0.00 | - |
| Stryker Corp. | 114.47 Bil. | 22.26 Bil. | 41.85 | +3.99 % | 0.00 | - |
| Siemens Healthineers AG | 51.40 Bil. | 23.38 Bil. | 24.04 | +10.40 % | 0.00 | - |
| Hoya Corp | 48.59 Bil. | 5.43 Bil. | 35.69 | +17.33 % | 0.00 | - |
| Becton Dickinson and Co. | 45.46 Bil. | 19.79 Bil. | 32.18 | -3.33 % | 0.00 | - |
| Edwards Lifesciences Corp | 42.15 Bil. | 5.38 Bil. | 47.11 | -27.44 % | 0.00 | - |
| Alcon AG | 33.20 Bil. | 9.24 Bil. | 38.41 | -7.56 % | 0.00 | - |
| ResMed Inc. | 32.17 Bil. | 4.73 Bil. | 27.14 | +36.48 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 165.4 G | 0 Units |
| PRICE DETERMINATION TIME | 06/18/2026 / 07:02:31 PM | |
| DAILY VOLUME (UNITS) | 458 | |
| DAILY HIGH / LOW | 169.2 | 160.5 |
| PREV. DAY'S PRICE | 175.1 | (06/17) |
| CHANGE DAY BEFORE | -9.70 | -5.54 % |
| 52 WEEK HIGH / LOW | 223.2 (01/07) | 150.4 (04/29) |
Key Figures (in EUR)
| 2027e | 2026e | 2025 | 2024 | 2023 | |
|---|---|---|---|---|---|
| EARNINGS PER SHARE | 6.05 | 5.07 | 2.73 | 1.81 | 3.36 |
| DIVIDENDS PER SHARE | 0.97 | 0.81 | 0.69 | 0.69 | 0.69 |
| DIVIDEND YIELD IN % | - | - | 0.33 % | 0.37 % | 0.29 % |
| DIVIDEND GROWTH IN % | - | - | 0.00 % | 0.00 % | -52.08 % |
| PRICE - EARNINGS RATIO | 29.02 | 34.64 | 76.93 | 104.29 | 71.27 |
| PRICE - BOOK RATIO | - | - | 5.00 | 4.61 | 8.37 |
| PRICE - SALES RATIO | - | - | 6.89 | 6.57 | 7.95 |
| PRICE - CASH FLOW RATIO | - | - | 37.94 | 28.61 | 35.05 |
Master Data
| WKN | A2AJKS |
| ISIN | FR0013154002 |
| SYMBOL | 56S1 |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | Sartorius Stedim Biotech |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | Euro |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Healthcare Equipment |
| NUMBER OF SHARES | 97.32 Mil. |
| MARKET CAPITALISATION | 24.50 Bil. |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | -1.41 % | 12.82 % | 0.32 % | -14.88 % | -10.62 % | -36.74 % | -53.42 % | -14.88 % |
| HIGH | 180.40 | 184.50 | 194.60 | 223.20 | 223.20 | 286.30 | 557.20 | 223.20 |
| LOW | 174.80 | 154.20 | 150.40 | 150.40 | 150.40 | 139.80 | 139.80 | 150.40 |
Dividend
per share
Company profile
Sartorius Stedim Biotech SA provides equipment and services for the development, quality assurance, and production processes of the biopharmaceutical industry. The firm offers a broad portfolio of products that focuses on all steps in the manufacture of a biopharmaceutical, as well as in process development as prerequisite procedures. Its technologies cover inter alia, cell line technologies, cell culture media, bioreactors, and a wide range of products for separation, purification, and concentration of biological intermediates and finished products, as well as solutions for storage and transportation. It also offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production. The company was founded on September 28, 1978 and is headquartered in Aubagne, France.
Structured products for Sartorius Stedim Biotech S.A.
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.